V Square Quantitative Management LLC Has $301,000 Stock Position in Solventum Co. (NYSE:SOLV)

V Square Quantitative Management LLC reduced its stake in shares of Solventum Co. (NYSE:SOLVFree Report) by 5.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 4,558 shares of the company’s stock after selling 280 shares during the period. V Square Quantitative Management LLC’s holdings in Solventum were worth $301,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of SOLV. Exchange Traded Concepts LLC acquired a new stake in Solventum during the 3rd quarter worth approximately $60,000. Blue Trust Inc. acquired a new stake in shares of Solventum in the third quarter valued at approximately $538,000. Copeland Capital Management LLC acquired a new stake in shares of Solventum in the third quarter valued at approximately $26,000. Foundations Investment Advisors LLC acquired a new stake in shares of Solventum in the third quarter valued at approximately $345,000. Finally, Sequoia Financial Advisors LLC raised its holdings in shares of Solventum by 8.3% in the third quarter. Sequoia Financial Advisors LLC now owns 5,737 shares of the company’s stock valued at $400,000 after purchasing an additional 441 shares during the last quarter.

Solventum Price Performance

NYSE:SOLV opened at $74.04 on Monday. Solventum Co. has a 1-year low of $47.16 and a 1-year high of $96.05. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The firm has a fifty day simple moving average of $70.75 and a 200 day simple moving average of $68.58.

Wall Street Analysts Forecast Growth

SOLV has been the topic of a number of recent research reports. Morgan Stanley lifted their price objective on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. Mizuho initiated coverage on shares of Solventum in a report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price objective on the stock. Finally, Piper Sandler lifted their price objective on shares of Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a report on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $68.29.

Check Out Our Latest Research Report on SOLV

Solventum Company Profile

(Free Report)

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

Recommended Stories

Want to see what other hedge funds are holding SOLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Solventum Co. (NYSE:SOLVFree Report).

Institutional Ownership by Quarter for Solventum (NYSE:SOLV)

Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.